AMR news related to Smart Innovations

For Scientists, Researchers and Innovating Professionals who want to stay adequately informed on Antimicrobial resistance, AMR Insights offers the most comprehensive overview of recently published, global news and information.


15 June 2020

Antibiotics Special Issue: Challenges and Opportunities in Antibiotic Discovery and Development

15 June 2020

A View from the Wellcome Trust Drug-Resistant Infections Priority Programme: Creating a Sustainable Research and Development Ecosystem to Meet the Global Need for Antibiotics

15 June 2020

How to Stimulate and Facilitate Early Stage Antibiotic Discovery

15 June 2020

NIAID’s Comprehensive Support Mechanisms for Antibiotic Development

15 June 2020

The Global Antibiotic Research and Development Partnership (GARDP) Not-for-Profit Model of Antibiotic Development

15 June 2020

On the Road to Discovering Urgently Needed Antibiotics: So Close Yet So Far Away

15 June 2020

The Antibacterial Research and Development Pipeline Needs Urgent Solutions

9 June 2020

Regulatory approval characteristics of antimicrobial versus non-antimicrobial products, 1984–2018: an evaluation of Food and Drug Administration flexibilities

9 June 2020

The REPAIR Impact Fund launches global call for new investment proposals to fight AMR

6 June 2020

FDA Approves Merck’s RECARBRIO™ for the Treatment of Adults with Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia

5 June 2020

A financial model for an impact investment fund for the development of antibacterial treatments and diagnostics

5 June 2020

A financial model for an impact investment fund for the development of antibacterial treatments and diagnostics

4 June 2020

Regulatory approval characteristics of antimicrobial versus non-antimicrobial products, 1984–2018: an evaluation of Food and Drug Administration flexibilities

3 June 2020

FDA Accepts Shionogi’s Supplemental New Drug Application with Priority Review for FETROJA® (cefiderocol) for the Treatment of Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

29 May 2020

CARB-X FUNDS MICROBION TO DEVELOP INHALED DRUG TO TREAT CYSTIC FIBROSIS-RELATED LUNG INFECTIONS

19 May 2020

CARB-X FUNDS FACILE THERAPEUTICS TO DEVELOP A NEW TREATMENT TO PREVENT RECURRING C. DIFFICILE BACTERIAL INFECTIONS

18 May 2020

Why a UK clinical trial could lead the way for antimicrobial resistance efforts

15 May 2020

The effects of gamification on antimicrobial resistance knowledge and its relationship to dentistry in Saudi Arabia: a randomized controlled trial

13 May 2020

How AI Could Revolutionise The Fight Against Antimicrobial Resistance

12 May 2020

Bioactive Phytocompounds to Fight Against Antimicrobial Resistance

11 May 2020

What If We Could Fight Antibiotic Resistance With Probiotics?

7 May 2020

Begin with the end in mind: designing synthetic antibiotics with a universal mechanism of action

7 May 2020

SMART researchers uncover new anti-phage defence mechanisms in bacteria

5 May 2020

A computerized decision support system (CDSS) for antibiotic prescription in primary care—Antibioclic: implementation, adoption and sustainable use in the era of extended antimicrobial resistance

4 May 2020

Fecal Transplantation Improves Outcomes in Patients with Multi-Drug Resistant Organisms

4 May 2020

New Insight into Bacterial Structure to Help Fight Against Superbugs

2 May 2020

WHO 2020 preclinical antibacterial pipeline data call open

2 May 2020

Venatorx Pharmaceuticals and GARDP partner to develop new antibiotic for hospital acquired infections with limited treatment options

1 May 2020

Peptide weakens superbugs to make old antibiotics effective again

1 May 2020

Childhood vaccines and antibiotic use in low- and middle-income countries

29 April 2020

New drug formulation could treat Candida infections

27 April 2020

Biopharma Start-Up Bugworks Raises $7.5 Mln In Fresh Financing

18 April 2020

DA Grants Breakthrough Device Designation to DNAe’s Sequencing Diagnostic

18 April 2020

Tracking the Global Pipeline of Antibiotics in Development, April 2020

17 April 2020

Antibacterial bioactive glass for bone reconstruction: A new approach to infection treatment

14 April 2020

Unyvero HPN and LRT Panels for Rapid Detection of Bacterial Co-Infections in COVID-19 Pneumonia

14 April 2020

Resistance of Gram-Negative Bacteria to Current Antibacterial Agents and Approaches to Resolve It

10 April 2020

The growing crisis in antibiotic R&D: opportunities for G20 member action to support sustainable innovation

9 April 2020

Accelerating surveillance and research of AMR – an online repository for sharing of antimicrobial susceptibility data associated with whole-genome sequences

7 April 2020

A real-world evaluation of a Case-Based Reasoning algorithm to support antimicrobial prescribing decisions in acute care

3 April 2020

Fighting the rise of antibiotic resistance

1 April 2020

Dynamic Dashboard launched

28 March 2020

Antimicrobial Properties on Non-Antibiotic Drugs in the Era of Increased Bacterial Resistance

28 March 2020

Bacteriophage Therapy: Developments and Directions

28 March 2020

Abundant Extractable Metabolites from Temperate Tree Barks: The Specific Antimicrobial Activity of Prunus Avium Extracts

26 March 2020

Forge Enters Into Collaboration with Roche to Develop Novel Antibiotic to Treat Lung Infections

25 March 2020

Latest news Grants awarded for implementation research to tackle the threat of antimicrobial resistance

21 March 2020

How could smart surfaces help tackle infection and antimicrobial resistance?

21 March 2020

Scientists describe promising rapid tests for antibiotic susceptibility

21 March 2020

Zinc can counteract selection for ciprofloxacin resistance



What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed